Medivir AB (FRA:MVR0)
€ 0.211 -0.017 (-7.46%) Market Cap: 27.91 Mil Enterprise Value: 14.54 Mil PE Ratio: 0 PB Ratio: 1.77 GF Score: 46/100

Q4 2021 Medivir AB Earnings Call Transcript

Feb 15, 2022 / 01:00PM GMT
Release Date Price: €0.632715 (-1.05%)
Operator

Ladies and gentlemen, welcome to the Medivir Audiocast Teleconference for Q4 2021. (Operator Instructions)

Today, I am pleased to present CEO, Jens Lindberg. Please begin.

Jens Lindberg;publ;CEO
Medivir AB

()-

Thank you. Welcome, everyone, to Medivir webcast. We'll do 1 thing first. We will go through the presentation today. There might be a bit of a lag from when we ask the slides to move forward until you see them move forward. So if you have the opportunity, you can also go into medivir.com under Investors & Presentations, and there, you can see today's presentations in PDF format.

So I'll stop and then pause for 60 seconds, and those of you who had the opportunity to download on medivir.com, I would encourage you to do so, and then we'll start in 60 seconds. So we'll do a bit of a pause. And we can -- with that, we can also move forward to the next slide as we are pausing. So you can go to Slide 2 in the meantime.

Okay, that was probably slightly shorter than 60 seconds, but we'll go anyway.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot